THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
186,489,933
Share change
+8,743,550
Total reported value
$710,578,290
Put/Call ratio
142%
Price per share
$3.81
Number of holders
133
Value change
+$23,585,017
Number of buys
58
Number of sells
74

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q4 2018

As of 31 Dec 2018, THERAPEUTICSMD INC - COM (TXMD) was held by 133 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 186,489,933 shares. The largest 10 holders included Bank of New York Mellon Corp, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, FMR LLC, BlackRock Inc., Vanguard Group Inc, FRANKLIN RESOURCES INC, DARUMA CAPITAL MANAGEMENT LLC, STATE STREET CORP, and Voya Investment Management LLC. This page lists 133 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.